CIK 0001574094 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
RenovoRx, Inc.
Sign in to watch- Ticker
- RNXT
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 271448452
- Phone
- 408-800-2649
- Business address
- 2570 W. EL CAMINO REAL, STE. 320,, MOUNTAIN VIEW, CA, 94040
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-18 | Bagai Shaun Chief Executive Officer | Purchase | +5,000 | $0.90 | $5K | 340,040 |
| 2025-12-17 | Bagai Shaun Chief Executive Officer | Purchase | +5,000 | $0.85 | $4K | 335,040 |
| 2025-12-16 | Agah Ramtin Chief Medical Officer | Purchase | +12,000 | $0.85 | $10K | 778,460 |
| 2025-12-05 | Agah Ramtin Chief Medical Officer | Purchase | +10,000 | $0.96 | $10K | 766,460 |
| 2025-11-24 | Agah Ramtin Chief Medical Officer | Purchase | +12,000 | $0.80 | $10K | 756,460 |
| 2025-11-21 | Agah Ramtin Chief Medical Officer | Purchase | +10,000 | $0.80 | $8K | 744,460 |
| 2025-10-01 | Marton Laurence Director | Grant or award · Stock Options (right to buy) | +47,640 | 47,640 | ||
| 2025-10-01 | Macfarlane K. Angela Director | Grant or award · Stock Options (right to buy) | +47,640 | 47,640 | ||
| 2025-10-01 | RYAN UNA S Director | Grant or award · Stock Options (right to buy) | +47,640 | 47,640 | ||
| 2025-10-01 | Spiegel Robert J. Director | Grant or award · Stock Options (right to buy) | +47,640 | 47,640 | ||
| 2025-08-25 | Bagai Shaun Chief Executive Officer | Purchase | +5,000 | $0.91 | $5K | 330,040 |
| 2025-08-22 | Bagai Shaun Chief Executive Officer | Purchase | +5,000 | $0.95 | $5K | 325,040 |
| 2025-07-01 | Agah Ramtin Chief Medical Officer | Grant or award · Stock Option | +63,636 | 63,636 | ||
| 2025-07-01 | Bagai Shaun Chief Executive Officer | Grant or award · Stock Option | +102,498 | 102,498 | ||
| 2025-07-01 | Gentry Leesa Chief Clinical Officer | Grant or award · Stock Option | +6,619 | 6,619 | ||
| 2025-07-01 | Kocak Ron VP, Controller and PAO | Grant or award · Stock Option | +41,600 | 41,600 | ||
| 2025-06-05 | Agah Ramtin Chief Medical Officer | Purchase | +21,000 | $1.40 | $29K | 734,460 |
| 2025-05-02 | Marton Laurence Director | Option exercise | +20,480 | $0.15 | $3K | 66,164 |
| 2025-05-02 | Marton Laurence Director | Option exercise · Stock Option (right to buy) | −20,480 | 0 | ||
| 2025-04-22 | Agah Ramtin Chief Medical Officer | Gift | −400,000 | 713,460 |
Page 2 of 6 · 120 trades